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Abstract
Background: The introduction of new vaccines for young children requires instruments for a
rapid and timely assessment of the progressively increasing vaccination coverage. We assessed
whether routine data generated by statutory health insurances (SHI) might be used to monitor
vaccination coverage in young children.
Methods: For 90% of the population Germany's healthcare system is premium-funded through
SHI. Specific medical codes on childhood vaccination are used for billing. These were used to
analyse vaccine uptake up to 24 months in children born in Bavaria between 2001–10–01 and 2002–
12–31. For children insured in the biggest SHI, vaccination coverage estimates based on billing data
were compared to estimates considering only continuously insured children since birth, based on
additional data provided by this SHI.
Results: Definition of an appropriate denominator from the billing data was a major challenge:
defining the denominator by any consultation by children with different ID numbers yielded
196,732 children, exceeding the number of births in Bavaria by a factor of 1.4. The main causes for
this inflated denominator were migration and change of health insurance number. A reduced
dataset based on at least one physician's visit in the first six months and 2nd year of life yielded
111,977 children. Vaccination coverage estimates for children in the biggest SHI were at maximum
1.7% higher than in the data set based on continuously insured children.
Conclusion: With appropriate adjustments to define the denominator physician's billing data
provide a promising tool to estimate immunisation coverage. A slight overestimation based on
these data was explained by children never seeing a physician.
Background
The WHO European Region strategic plan aims not only
to attain high levels of childhood immunisations but also
to provide maximum protection at an earliest possible age
and to reduce geographical disparities in vaccination cov-
erage [1]. Despite the fact that Germany has acknowl-
edged these goals, this country has one of the lowest
vaccination coverage rates in Europe [2], the administra-
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tion of all recommended vaccines in children is consider-
ably delayed and a high geographical variance between its
16 states exists (e.g. range for 1st dose measles immunisa-
tion at 2 years: 58 – 88%) [3].
Although the need to establish a system for monitoring
completeness and timeliness of immunisations is
acknowledged, in many countries there are no registries
for such data [4,5]. Therefore estimation of vaccination
coverage in most countries is based on either ad hoc sur-
veys of representative samples or on assessment during
school health examinations or both [6-8]. Despite the
undoubted usefulness of these data in the absence of bet-
ter sources, they have several limitations: surveys are
fraught with problems regarding completeness, sample
size, representativity and immense costs, and school
health examinations lag 5 to 6 years behind the current
vaccination practice and do not assess types of vaccines or
timing of vaccinations.
In countries like Germany, France and the US, childhood
immunisations are mainly given by the private sector
(paediatricians and general practitioners) [4,9]. Although
these physicians get paid for vaccinating, imbursement
data related to vaccination have not been used to assess
vaccination coverage in a systematic manner.
In a cohort of children born between 2001–10–01 and
2002–12–31 in Bavaria, the second most densely popu-
lated German state, we therefore assessed whether such
imbursement data might be useful to depict the vaccine
uptake up to the age of 24 months.
Methods
The SHI system and the Association of SHI Physicians in 
Germany
Germany's healthcare system is premium-funded through
statutory health insurances (SHI) for 90% of the popula-
tion. There are about 115,000 physicians providing out-
patient services within SHI in Germany. SHI pay for
services of outpatient physicians through regional associ-
ations of SHI physicians which handle all billing informa-
tion on an individual basis. To bill patients, outpatient
physicians are obliged to be members of a regional branch
of the 'Kassenärztliche Vereinigung' (KV). For payment,
physicians submit electronic invoices based on medical
codes for each visit to the KV. Any physicians' contacts and
preventive measures, such as vaccinations, can be identi-
fied on the basis of a specific medical code. Each of the 16
states in Germany has at least one regional KV. Data of the
Bavarian KV (KVB) allow identifying the different vaccine
antigens administered at vaccination visits since July
2001.
Patients and setting
Data of the KVB were used. Bavaria is the largest (70,552
km2) and the second most populated state of Germany
with 12 million inhabitants [10]. We analysed physicians'
consultations and vaccination histories for children born
between 2001–10–01 and 2002–12–31 with a follow-up
until 2004–12–31, allowing for analysis of any billing for
these children up to an age of at least 24 months.
Nature and structure of data
The KVB supplied data of all patient consultations that
were billed by outpatient physicians on a quarterly basis.
Each patient has a unique identification code within his
SHI. This may change in case the patient changes the SHI,
which does occur because of competition between SHI.
The child's vaccination history therefore is completely
mapped by the billing data unless the child switches to
another SHI or to a physician outside of Bavaria during
the observation period. The following data were available
for the statistical analysis of the KVB data set: an identifi-
cation code, member of the major health insurance com-
pany of Bavaria (AOK Bavaria; yes/no), birth date of the
child, date of consultancy and – if vaccinated – 4- to 5-
digit codes identifying the vaccines administered, or con-
sultancy for any other reason per quartile year.
Data analysis
To calculate vaccination coverage, the number of vacci-
nated children (numerator) and the total number of chil-
dren eligible for vaccination (denominator) has to be
known. While numerator data are directly provided in the
KVB dataset, an appropriate denominator has to be
derived from KVB data. A child not consulting a Bavarian
outpatient physician or not insured in SHI will not appear
in the KVB data. A simple approach to assess the number
of children eligible for vaccination within the SHI is to
consider all children with any physician billing up to
2004–12–31 (original KVB dataset). This approach does
not take the following censoring events into account: (a)
children migrating from or to Bavaria; (b) children treated
by a Bavarian physician during their holidays and there-
fore leaving or entering responsibility of the KVB; (c) chil-
dren changing between different SHI or between private
health insurances and SHI. The magnitude of these prob-
lems and its influence on vaccination coverage estimates
was not known. We therefore compared two datasets: (1)
the original KVB dataset, consisting of all children with at
least one physicians' visit during the defined follow-up
period; and (2) a reduced KVB dataset, applying a simple
algorithm which restricts the original dataset to a cohort
of children with at least two physicians' visits, independ-
ent of its medical character.BMC Public Health 2008, 8:82 http://www.biomedcentral.com/1471-2458/8/82
Page 3 of 6
(page number not for citation purposes)
Validation
The number of children in the two KVB datasets for a
Bavarian birth cohort born 2001–10–01 to 2002–12–31
is compared to the official numbers provided by the
Bavarian Bureau of Statistics [10] and differences will be
analysed.
Vaccination coverage is assessed both for the original and
the reduced KVB dataset. Furthermore, to check if the
reduction strategy of the KVB dataset was valid, additional
information from one health insurance company of
Bavaria (AOK) was obtained. The aim was to define a pop-
ulation that was continuously insured with one SHI dur-
ing the observation period. The AOK Bavaria supplied
data on all children born between 2001–10–01 and
2002–12–31 who were continuously insured in the AOK
Bavaria from birth to 2004–12–31. The following data
were available: an identification code, birth date of the
child, date of entrance to and exit from the insurance. The
vaccination histories of the children in the AOK dataset
could be obtained by linking the AOK identification
number to the identification number for AOK insured
children in the KVB dataset. Vaccination coverage esti-
mates from children continuously insured in the AOK
Bavaria is compared to those from a reduced KVB dataset
for AOK insured children only.
Definitions for vaccination status
According to the German vaccination schedule [11] we
defined a child as 'fully primed' if he or she received at
least three doses of a vaccine containing acellular pertussis
components or two doses of a vaccine not containing acel-
lular pertussis components. A child was defined as 'fully
immunized' if she or he received a booster dose at the age
of 11 months or later following full priming. In accord-
ance to the above definitions, we estimated the coverage
of the following combined series: first dose, full priming
and full immunisation against diphtheria, tetanus, pertus-
sis, polio, Haemophilus influenzae type b and hepatitis B;
first dose against measles, mumps and rubella (MMR) [7].
Uptake and timing of immunisation by age in months
was calculated according to the Kaplan-Meier method
which is described in detail by Laubereau et al. [12].
All data provided by the KVB and analysed in the Institute
for Social Pediatrics and Adolescent Medicine, Munich,
were completely anonymous in accordance with German
data protection laws.
Results
The original KVB dataset yields data on 196,732 children
born between 2001–10–01 and 2002–12–31. This is
more than the respective number of children born in
Bavaria in the observation period (n = 142,809) [10]. The
inflated denominator can be explained by (1) children
migrating to Bavaria or consulting a Bavarian physician in
their holidays and (2) children changing health insurance
companies; these children will be recorded more than
once because of changing insurance numbers. The timing
of these censoring events is not recorded in the KVB data-
sets and therefore cannot be considered in the analysis. In
order to deal with this problem, we reduced the original
KVB dataset. Since we were interested in vaccine uptake in
the first two years of life we required one visit in the first
half of life and one in the second year of life – in order to
make sure that this identified cohort was followed-up
until the second year of life. This algorithm yielded a data-
set with 111,799 children, corresponding to 78% of all
children born in Bavaria during the observation period.
The reduced KVB dataset cohort is smaller than the respec-
tive birth cohorts defined by official data [10]. The differ-
ence in the number of children in the reduced dataset
compared to the respective Bavarian birth cohort and the
magnitude of different causes is shown in table 1: (1) chil-
dren who are privately insured can not appear in the KVB
dataset, (2) children who change insurance and therefore
could not be followed-up will not appear in the reduced
Table 1: The reduced KVB dataset compared to the respective Bavarian birth cohorts and causes for the observed differences.
percent N
Bavarian birth cohorts (1.10.2001–31.12.2002) [9] 100 142,809
Reduced KVB dataset 78 111,977
difference 30,832
Reasons:
privately insured+ 10.0 14,281
change of insurance* 5.0–8.0 7,140–11,425
no consultancy of outpatient physician in 1st 6 months and 2nd year of life* 4.9 6,998
moving from Bavaria [9] 1.4 1,999
* estimated from AOK Bavaria data (own data)
+ personal communication of Dr. Frank Niehaus, WIP-PKV (scientific Institute of the Private Health Insurances)BMC Public Health 2008, 8:82 http://www.biomedcentral.com/1471-2458/8/82
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dataset, (3) children who never consulted an outpatient
physician or not consulted an outpatient physician in
their first six months and in the second year of life will not
appear in the reduced dataset, nor will (4) children who
move from Bavaria.
The number of children in the validation AOK dataset was
40,645. 95.1% of the children in the validation dataset
had visited an outpatient physician in the first six months
of life and in the second year of life, which was the algo-
rithm to generate the reduced KVB dataset from the origi-
nal KVB dataset. The proportion of children not
consulting a physician in both periods was 3.1%, the pro-
portion of children never visiting a physician was 1.8%.
The reduced KVB dataset on AOK insured children (n =
44,755), however, was even greater than the number of
children in the provided AOK dataset; this is explained by
children in the reduced KVB dataset with at least one phy-
sician's visit in the second year of life who may have left
the AOK before 2004–12–31 whereas the validation data-
set required all children to be continuously insured from
birth to 2004–12–31.
In table 2 point estimates of vaccination coverage with
95% confidence intervals derived from the four different
datasets are shown: the original and the reduced KVB
dataset; a subset of the reduced KVB dataset which only
includes AOK insured children; and a dataset for children
continuously insured in the AOK (validation dataset). The
vaccination coverage estimates of the reduced KVB dataset
were lower than those for the original KVB dataset. The
reduced KVB dataset on AOK insured children and the
AOK validation dataset point to slightly higher vaccina-
tion coverage estimates in AOK insured children. In the
reduced KVB dataset on AOK Bavaria insured children the
vaccination coverage estimates were up to 1.7% higher
than those for the AOK validation dataset with disjunctive
95% confidence intervals.
Figure 1 shows uptake and timing of the first and second
MMR immunisation by age using inverse Kaplan-Meier
curves is shown in relation to the age recommended by
the German Standing Committee on Vaccination [11].
Discussion
These data from Bavaria show that using routine data gen-
erated by SHI to handle physicians' billings may provide
a useful tool to estimate immunisation uptake in the first
two years of life in Germany.
The main challenge in using routine data generated by
SHI to handle physicians' billings is to define an appropri-
ate denominator. Considering all different insurance
numbers related to any physicians' billing as a surrogate
for the number of children eligible for vaccination (origi-
nal KVB dataset) will yield to a huge overestimation of the
denominator and therefore to an underestimation of vac-
cination coverage estimates.
A restriction to children with at least two visits – one in the
first six months and one in the second year of life –
reduces the original dataset to 78% of the size of the
Bavarian birth cohort. The impact of this algorithm could
be assessed with the AOK validation dataset: only 3.1% of
all children did not visit an outpatient physician in these
two periods. The high proportion of children seen by a
physician in their first two years of life might be a conse-
quence of free of charge well baby check-up visits in the
first two years (U1-U7) with a compliance of 80% – 90%
for each check-up [13].
The vaccination coverage estimates for the reduced KVB
dataset on AOK insured children gave similar vaccination
Table 2: Comparison of vaccination coverage estimates (%; 95% CI) between the two KVB datasets, the dataset for AOK insured 
children in the reduced KVB cohort and the validation data set for two different vaccinations at different children's ages.
Vaccination coverage (%)
DTPPolioHibHep
Data Set N MMR 1st dose at 2 y 1st dose at 3 months Full primed at 1 y Full immunized at 2 y
Original KVB dataset 196,732 60.4 14.6 45.7 40.4
60.2–60.7 14.4–14.8 45.5–45.9 40.2–40.7
Reduced KVB dataset 111,977 75.4 22.3 67.5 56.0
75.1–75.6 22.1–22.6 67.0–67.6 55.7–56.3
Subset of the reduced KVB data set (AOK 
Bavaria insured only)
44,755 77.2 24.1 70.5 57.7
76.8–77.6 23.7–24.5 70.1–71.0 57.3–58.2
Validation data set 40,645 76.0 23.1 68.8 56.6
75.5–76.4 22.7–23.5 68.3–69.2 56.1–57.1BMC Public Health 2008, 8:82 http://www.biomedcentral.com/1471-2458/8/82
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coverage estimates as for the AOK validation dataset.
These were, however, up to 1.7% higher than for the AOK
validation dataset. This systematic overestimation of vac-
cination coverage based on KVB data might be explained
by children never consulting an outpatient physician –
some 1.8% of the children in the AOK validation dataset.
These children will not be vaccinated and – as they are not
included in the denominator of the reduced KVB dataset
– vaccination coverage is slightly overestimated in the
reduced KVB dataset. It might be argued to confine vacci-
nation coverage estimates to the app. 30% AOK insured
children in Bavaria. Unfortunately such data are not rou-
tinely available – they were generated on special request
for this study.
The vaccination coverage estimates presented here are not
based on the entire Bavarian birth cohort. In table 1
causes for the missing 22% were plausibly explained.
There are no data, however, to suggest that vaccination
coverage for children in families moving out of Bavaria
and those changing SHI should be different from the
entire cohort. Vaccination coverage of privately insured
children might differ since these children are from fami-
lies who are exempted from the SHI system because their
parents' income exceeds a certain threshold. The direction
of the possible bias for vaccination coverage in this sub-
group, however, is difficult to estimate: while parents with
predominantly higher education levels might be more
careful to have there children vaccinated in time, this cli-
entele also includes parents attracted by 'alternative' med-
icine who are reluctant about vaccinations.
The vaccination coverage estimates generated from billing
data for SHI insured children allow depicting the vaccine
uptake as a time dependent variable. As shown exempla-
rily in the figure, the MMR vaccination has not only a low
coverage with 24 months of age, but also exists a consid-
erably delay in its administration: at the end of the recom-
mended age (15 and 24 months for the first and second
dose, respectively) less than 50% of the children were vac-
cinated with the respective dose. A similar picture appears
for all other generally recommended vaccines (data not
shown). Comparably low and delayed vaccination cover-
age estimates in young children have been shown by a
national immunisation survey [3], but when restricting
these data to Bavarian children only extremely wide con-
fidence intervals derive.
Conclusion
The outlined use of SHI billing data to estimate vaccina-
tion coverage appears to be a promising approach for low
cost in countries where vaccinations are administered by
the private sector. The size of a systematic overestimation
of vaccination coverage due to children never seeing an
outpatient physician and therefore not appearing in data-
sets based on billing data was found to be small. This data
source might provide a useful tool for rapid assessment of
progressively increasing vaccination uptake by newly
introduced vaccines.
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Vaccination covarage estimates for MMR derived from the reduced KVB dataset Figure 1
Vaccination covarage estimates for MMR derived from the reduced KVB dataset. Inverse Kaplan-Meier curves (95% CI) indicat-
ing the proportion of children vaccinated by age of child at first (left) or second (right) MMR vaccination. Shaded areas mark 
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